chitosan has been researched along with Black Fever in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (84.62) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Covre, LP; de Matos Guedes, HL; Gomes, DCO; Lopes, UG; Ré, MI; Rossi-Bergmann, B; Schwedersky, RP; Souza, BLDSC | 1 |
Çetin Uyanikgil, EÖ; Gürbüz Çolak, N; Özbel, Y; Töz, S | 1 |
Bora, HK; Chaurasia, M; Chourasia, MK; Dube, A; Gayen, JR; Jaiswal, AK; Meher, JG; Pawar, VK; Raval, K; Singh, PK; Singh, Y; Srikanth, CH | 1 |
Chaubey, P; Chaurasia, S; Mishra, B; Monteiro, M; Mudavath, SL; Patel, RR; Sundar, S; Suvarna, V | 1 |
Akhtar, S; Gendelman, HE; Nadhman, A; Rehman, AU; Saljoughian, N; Sarwar, HS; Satoskar, AR; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
Chaubey, P; Mishra, B | 1 |
Chaubey, P; Mishra, B; Patel, RR | 1 |
Asthana, S; Chourasia, MK; Dube, A; Gupta, A; Jain, V; Jaiswal, AK; Pawar, VK | 1 |
Asthana, S; Dube, A; Dwivedi, P; Gupta, PK; Jaiswal, AK; Kumar, V; Mishra, PR; Shukla, P; Verma, A | 1 |
Bose, PP; Dwivedi, MK; Kumar, P | 1 |
Akhtar, S; Edagwa, BJ; Gendelman, HE; McMillan, J; Qureshi, NA; Raza, A; Shahnaz, G; Yasinzai, M | 1 |
Chourasia, MK; Dube, A; Dwivedi, AK; Gupta, S; Kunjachan, S | 1 |
Asthana, S; Chourasia, MK; Dube, A; Gupta, PK; Jaiswal, AK; Pawar, VK | 1 |
13 other study(ies) available for chitosan and Black Fever
Article | Year |
---|---|
Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis.
Topics: Animals; Antigens, Protozoan; Chitosan; Immunity, Cellular; Immunization; Leishmania infantum; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Protozoan Proteins; Vaccination; Vaccines, DNA | 2022 |
The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Female; Gels; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Polymers | 2022 |
Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Cricetinae; Cytokines; Drug Carriers; Drug Compounding; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Micelles; Poloxamer; Tissue Distribution | 2017 |
Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
Topics: Cell Line; Chitosan; Curcumin; Drug Carriers; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Nanoparticles | 2018 |
Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Biological Availability; Cell Membrane; Chitosan; Drug Carriers; Drug Compounding; Immunomodulation; Leishmaniasis, Visceral; Mannose; Mice; Nanoparticles; Nitric Oxide; Particle Size; Permeability; Safety; Tissue Distribution | 2018 |
Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
Topics: Animals; Biological Transport; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Leishmaniasis, Visceral; Male; Mannose; Nanoparticles; Rats; Rifampin | 2014 |
Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Topics: Animals; Biological Transport; Chemistry, Pharmaceutical; Chitosan; Curcumin; Drug Carriers; Drug Stability; Hydrogen-Ion Concentration; Leishmaniasis, Visceral; Male; Mannose; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanoparticles; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2014 |
Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Emulsions; Immunotherapy; Leishmania donovani; Leishmaniasis, Visceral; Lipids; Mice; Nanoparticles | 2014 |
Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
Topics: Alginates; Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mesocricetus; Nanoparticles; Rats, Wistar; Stearates | 2015 |
Hemoglobin guided nanocarrier for specific delivery of amphotericin B to Leishmania infected macrophage.
Topics: Amphotericin B; Cells, Cultured; Chitosan; Chondroitin Sulfates; Drug Carriers; Hemoglobins; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Nanoparticles | 2016 |
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Nanoparticles | 2017 |
Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Chitosan; Cricetinae; Doxorubicin; Drug Carriers; Drug Evaluation, Preclinical; Leishmaniasis, Visceral; Macrophages; Mesocricetus; Mice | 2011 |
Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Cricetinae; Leishmaniasis, Visceral; Male; Nanocapsules | 2013 |